The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents

Trends in Molecular Medicine

Volumn 8, Issue 4, 2002, Pages 174-179

  Mathieu, Chantal ^a   Adorini, Luciano ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b BioXell SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

20 EPICALCITRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; IMMUNOMODULATING AGENT; LEXACALCITOL; PARICALCITOL; RO 24 2637; RO 27 3049; RO 63 2023; TX 527; UNCLASSIFIED DRUG;

ALLOGRAFT; AUTOIMMUNE DISEASE; BONE METABOLISM; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG MECHANISM; GRAFT REJECTION; HORMONAL REGULATION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; OSTEOPOROSIS; PSORIASIS; REVIEW; SECONDARY HYPERPARATHYROIDISM; VITAMIN D METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; CALCITRIOL; GRAFT REJECTION; HUMANS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES;

EID: 0036220629     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02294-3     Document Type: Review

References (66)

1. Immunomodulatory effects of 1,25-dihydroxyvitamin D3
2. Vitamin D: Its role and uses in immunology
3. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed
4. Ligands for the vitamin D endocrine system: Different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein
5. Gene regulation by vitamin D3
6. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes
7. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol
8. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system
9. In vitro and in vivo analysis of the immune system of vitamin D receptor-knock out mice
10. Targeted ablation of the 25-hydroxyvitamin D1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction
11. Vitamin D analogs: Mechanism of action and therapeutic applications
12. Recent developments in the use of vitamin D analogues
13. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
14. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation
15. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation
16. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA
17. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions
18. 3
19. 3: Direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor
20. 3-mediated effects
21. 3: A transcriptional modulator of the IFN-γ gene
22. 3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-β1 and IL-4
23. + T cells to enhance the development of Th2 cells
24. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543)
25. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis
26. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-κB downregulation in transcriptional repression of the p40 gene
27. 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation
28. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells
29. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs
30. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro
31. 3 and mycophenolate mofetil treatment mediate transplantation tolerance
32. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo
33. Identification and immune regulation of 25-hydroxyvitamin D-1-α-hydroxylase in murine macrophages
34. Extrarenal production of calcitriol
35. 1,25-Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25(OH)2D3 on lymphocytes
36. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element
37. Effects of corticosteroid and 1,24R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice
38. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis
39. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
40. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia
41. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis
42. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease
43. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3
44. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060
45. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine
46. Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol
47. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3
48. MC 1288 - A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts
49. 1alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts
50. Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation
51. A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice
52. Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice
53. Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model
54. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts
55. 3) has salutary effects on renal allograft function
56. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A
57. Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: Treatment with 1,25(OH)2D3 restores defect
58. Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants
59. Partial protection of 1 alpha-hydroxyvitamin D3 against the development of diabetes induced by multiple low-dose streptozotocin injection in CD-1 mice
60. 3
61. 3 on the induction of experimental autoimmune thyroiditis
62. 3 Clin
63. 3
64. Single and combined effects of the vitamin D analogue KH1060 and cyclosporinA on mercuric-chloride-induced autoimmune disease in the BN rat
65. Effects of vitamin D3 and cyclosporin A on HgCl2-induced autoimmunity in brown Norway rats
66. MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation